chrX-123184572-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The NM_000828.5(GRIA3):c.37C>T(p.Arg13Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000497 in 1,207,778 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.0000046 ( 0 hom. 3 hem. )
Consequence
GRIA3
NM_000828.5 missense
NM_000828.5 missense
Scores
4
10
Clinical Significance
Conservation
PhyloP100: 3.39
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.41909227).
BP6
Variant X-123184572-C-T is Benign according to our data. Variant chrX-123184572-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3282688.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIA3 | NM_000828.5 | c.37C>T | p.Arg13Trp | missense_variant | 1/16 | ENST00000622768.5 | NP_000819.4 | |
GRIA3 | NM_007325.5 | c.37C>T | p.Arg13Trp | missense_variant | 1/16 | ENST00000620443.2 | NP_015564.5 | |
GRIA3 | NM_001256743.2 | c.37C>T | p.Arg13Trp | missense_variant | 1/4 | NP_001243672.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIA3 | ENST00000620443.2 | c.37C>T | p.Arg13Trp | missense_variant | 1/16 | 1 | NM_007325.5 | ENSP00000478489 | P4 | |
GRIA3 | ENST00000622768.5 | c.37C>T | p.Arg13Trp | missense_variant | 1/16 | 5 | NM_000828.5 | ENSP00000481554 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000903 AC: 1AN: 110729Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32937
GnomAD3 genomes
AF:
AC:
1
AN:
110729
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32937
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183481Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67911
GnomAD3 exomes
AF:
AC:
2
AN:
183481
Hom.:
AF XY:
AC XY:
0
AN XY:
67911
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000456 AC: 5AN: 1097049Hom.: 0 Cov.: 29 AF XY: 0.00000828 AC XY: 3AN XY: 362421
GnomAD4 exome
AF:
AC:
5
AN:
1097049
Hom.:
Cov.:
29
AF XY:
AC XY:
3
AN XY:
362421
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000903 AC: 1AN: 110729Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32937
GnomAD4 genome
AF:
AC:
1
AN:
110729
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32937
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 04, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T;T;.;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.;.;N;N
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Benign
T
Sift4G
Uncertain
D;T;D;T;T;T
Polyphen
0.86, 0.91
.;P;.;.;P;P
Vest4
MutPred
Loss of MoRF binding (P = 0.0301);Loss of MoRF binding (P = 0.0301);Loss of MoRF binding (P = 0.0301);Loss of MoRF binding (P = 0.0301);Loss of MoRF binding (P = 0.0301);Loss of MoRF binding (P = 0.0301);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at